Demonstrating the C-terminal boundary of the HIV 1 fusion conformation in a dynamic ongoing fusion process and implication for fusion inhibition

FASEB Journal

Volumn 21, Issue 13, 2007, Pages 3677-3684

  Wexler Cohen, Yael ^a   Shai, Yechiel ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Coiled coil; Envelope protein; Heptad repeat; HIV 1 inhibition; Lipopeptides; Peptide membrane interaction; T 20; Virus entry

Indexed keywords

VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN LIPID INTERACTION; VIRUS CELL INTERACTION;

HIV-1; MEMBRANE FUSION; PROTEIN CONFORMATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 35948978102     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-8582com     Document Type: Article

References (33)

1. Zhang, C. W., Chishti, Y., Hussey, R. E., and Reinherz, E. L. (2001) Expression, purification, and characterization of recombinant HIV gp140. The gp41 ectodomain of HIV or simian immunodeficiency virus is sufficient to maintain the retroviral envelope glycoprotein as a trimer. J. Biol. Chem. 276, 39577-39585
2. Center, R. J., Leapman, R. D., Lebowitz, J., Arthur, L. O., Earl, P. L., and Moss, B. (2002) Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface. J. Virol. 76, 7863-7867
3. Clapham, P. R., and McKnight, A. (2002) Cell surface receptors, virus entry and tropism of primate lentiviruses. J. Gen. Virol. 83, 1809-1829
4. Chan, D. C., and Kim, P. S. (1998) HIV entry and its inhibition. Cell. 93, 681-684
5. Eckert, D. M., and Kim, P. S. (2001) Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 70, 777-810
6. Furuta, R. A., Wild, C. T., Weng, Y., and Weiss, C. D. (1998) Capture of an early fusion-active conformation of HIV-1 gp41. Nat. Struct. Biol. 5, 276-279
7. Melikyan, G. B., Egelhofer, M., and von Laer, D. (2006) Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion. J. Virol. 80, 3249-3258
8. Colman, P. M., and Lawrence, M. C. (2003) The structural biology of type I viral membrane fusion. Nat. Rev. Mol. Cell. Biol. 4, 309-319
9. Chan, D. C., Fass, D., Berger, J. M., and Kim, P. S. (1997) Core structure of gp41 from the HIV envelope glycoprotein. Cell. 89, 263-273
10. Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., and Wiley, D. C. (1997) Atomic structure of the ectodomain from HIV-1 gp41. Nature. 387, 426-430
11. Skehel, J. J., and Wiley, D. C. (1998) Coiled coils in both intracellular vesicle and viral membrane fusion. Cell. 95, 871-874
12. Sollner, T. H. (2004) Intracellular and viral membrane fusion: a uniting mechanism. Curr. Opin. Cell Biol. 16, 429-435
13. Jiang, S., Lin, K., Strick, N., and Neurath, A. R. (1993) HIV-1 inhibition by a peptide. Nature. 365, 113
14. LaBranche, C. C., Galasso, G., Moore, J. P., Bolognesi, D. P., Hirsch, M. S., and Hammer, S. M. (2001) HIV fusion and its inhibition. Antiviral. Res. 50, 95-115
15. Wild, C., Greenwell, T., and Matthews, T. (1993) A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. AIDS Res. Hum. Retroviruses. 9, 1051-1053
16. Wild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B., and Matthews, T. J. (1994) Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. U. S. A. 91, 9770-9774
17. Lawless, M. K., Barney, S., Guthrie, K. I., Bucy, T. B., Petteway, S. R., Jr., and Merutka, G. (1996) HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41. Biochemistry 35, 13697-13708
18. Rimsky, L. T., Shugars, D. C., and Matthews, T. J. (1998) Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides. J. Virol. 72, 986-993
19. Munoz-Barroso, I., Durell, S., Sakaguchi, K., Appella, E., and Blumenthal, R. (1998) Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J. Cell Biol. 140, 315-323
20. Ryu, J. R., Jin, B. S., Suh, M. J., Yoo, Y. S., Yoon, S. H., Woo, E. R., and Yu, Y. G. (1999) Two interaction modes of the gp41-derived peptides with gp41 and their correlation with antimembrane fusion activity. Biochem. Biophys. Res. Commun. 265, 625-629
21. Kliger, Y., Gallo, S. A., Peisajovich, S. G., Munoz-Barroso, I., Avkin, S., Blumenthal, R., and Shai, Y. (2001) Mode of action of an antiviral peptide from HIV-1. Inhibition at a post-lipid mixing stage. J. Biol. Chem. 276, 1391-1397
22. Liu, S., Lu, H., Niu, J., Xu, Y., Wu, S., and Jiang, S. (2005) Different from the HIV fusion inhibitor C34, the anti-HIV drug fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120. J. Biol. Chem. 280, 11259-11273
23. Wexler-Cohen, Y., Johnson, B. T., Puri, A., Blumenthal, R., and Shai, Y. (2006) Structurally altered peptides reveal an important role for N-terminal heptad repeat binding and stability in the inhibitory action of HIV-1 peptide DP178. J. Biol. Chem. 281, 9005-9010
24. Gerber, D., Pritsker, M., Gunther-Ausborn, S., Johnson, B., Blumenthal, R., and Shai, Y. (2004) Inhibition of HIV-1 envelope glycoprotein-mediated cell fusion by a DL-amino acid-containing fusion peptide: possible recognition of the fusion complex. J. Biol. Chem. 279, 48224-48230
25. Sal-Man, N., Gerber, D., and Shai, Y. (2004) Hetero-assembly between all-L- and all-D-amino acid transmembrane domains: forces involved and implication for inactivation of membrane proteins. J. Mol. Biol. 344, 855-864
26. Weiss, A., Wiskocil, R. L., and Stobo, J. D. (1984) The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J. Immunol. 133, 123-128
27. Merrifield, R. B., Vizioli, L. D., and Boman, H. G. (1982) Synthesis of the antibacterial peptide cecropin A (1-33). Biochemistry 21, 5020-5031
28. Huerta, L., Lamoyi, E., Baez-Saldana, A., and Larralde, C. (2002) Human immunodeficiency virus envelope-dependent cell-cell fusion: a quantitative fluorescence cytometric assay. Cytometry 47, 100-106
29. Steger, H. K., and Root, M. J. (2006) Kinetic dependence to HIV-1 entry inhibition. J. Biol. Chem. 281, 25813-25821
30. Peisajovich, S. G., Gallo, S. A., Blumenthal, R., and Shai, Y. (2003) C-terminal octylation rescues an inactive T20 mutant - implications for the mechanism of HIV/simian immunodeficiency virus-induced membrane fusion. J. Biol. Chem. 278, 21012-21017
31. Zhu, P., Liu, J., Bess, J., Jr., Chertova, E., Lifson, J. D., Grise, H., Ofek, G. A., Taylor, K. A., and Roux, K. H. (2006) Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441, 847-852
32. Zanetti, G., Briggs, J. A., Grunewald, K., Sattentau, Q. J., and Fuller, S. D. (2006) Cryo-Electron Tomographic structure of an immunodeficiency virus envelope complex in situ (Online). PLoS Pathog. 2, e83
33. Judice, J. K., Tom, J. Y., Huang, W., Wrin, T., Vennari, J., Petropoulos, C. J., and McDowell, R. S. (1997) Inhibition of HIV type 1 infectivity by constrained alpha-helical peptides: implications for the viral fusion mechanism. Proc. Natl. Acad. Sci. U. S. A. 94, 13426-13430